Fisher & Paykel Healthcare Corporation Limited is a designer, manufacturer and marketer of heated humidification devices used in respiratory care and in the treatment of obstructive sleep apnea. Fisher & Paykel Healthcare is also engaged in manufacturing and marketing of patient warming and neonatal care products, infant resuscitators and continuous positive airway pressure systems designed to improve infant respiratory function. The company’s products are sold all over the world. Its head office and manufacturing are located in New Zealand.
Covering analysts: ABN AMRO, Citigroup Investment Research, Credit Suisse, Deutsche Bank Research, DJ Carmichael & Co, Linwar Securities, Macquarie Research Equities
FPH Market Data
Currency
New Zealand Dollars
52 Week High
NZ$3.55
52 Week Low
NZ$2.14
Shares Issued
511.25m
Market Cap
NZ$1,508.18m
What The Brokers Say
Strong Buy
3
Buy
1
Neutral
3
Sell
1
Strong Sell
0
Total
8
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.